Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes

ISSN： 0929-5666

Source： Letters in Peptide Science, Vol.10, Iss.5, 2003-01, pp. : 545-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Design of Peptide-based Inhibitors of Human Islet Amyloid Polypeptide Fibrillogenesis

By Scrocchi L.A. Chen Y. Waschuk S. Wang F. Cheung S. Darabie A.A. McLaurin J. Fraser P.E.

Journal of Molecular Biology, Vol. 318, Iss. 3, 2002-05 ,pp. : 697-706

Academic Press

Access to resources Recommend Favorite

Islet Amyloid Polypeptide and Diabetes

Current Protein and Peptide Science, Vol. 14, Iss. 4, 2013-06 ,pp. : 330-337

Bentham Science Publishers

Access to resources Recommend Favorite

Islet Amyloid Polypeptide: Identification of Long-range Contacts and Local Order on the Fibrillogenesis Pathway

By Padrick S.B. Miranker A.D.

Journal of Molecular Biology, Vol. 308, Iss. 4, 2001-05 ,pp. : 783-794

Academic Press

Access to resources Recommend Favorite

Renal Elimination of Islet Amyloid Polypeptide

By Leckstrom A. Bjorklund K. Permert J. Larsson R. Westermark P.

Biochemical and Biophysical Research Communications, Vol. 239, Iss. 1, 1997-10 ,pp. : 265-268

Elsevier

Access to resources Recommend Favorite

Encapsulated porcine islet transplantation: an evolving therapy for the treatment of Type I diabetes

By Thanos CG Elliott RB

Expert Opinion on Biological Therapy, Vol. 9, Iss. 1, 2009-01 ,pp. : 29-44

Informa Healthcare

Access to resources Recommend Favorite